Search
A new imaging approach being investigated by Memorial Sloan Kettering researchers could provide better information about a tumor’s molecular activity, allowing for a more accurate diagnosis.
A collaboration between MSK and Weill Cornell Medicine discovered a new relationship between cancer cells and the immune system, and shows how cancer can selfishly hijack a normally helpful immune pathway.
In honor of Minority Cancer Awareness Month, Dr. Brown shared information about cancer disparities, the importance of cancer screening, and MSK's health equity work.
Twelve students have successfully defended their dissertations and will receive their PhD degrees at Commencement on May 14.
Learn about a clinical trial at Memorial Sloan Kettering that is using plasma donated by MSK employees who have recovered from COVID-19.
Hepatic arterial infusion chemotherapy given to colorectal cancer patients with liver metastases extends their survival by almost two years, according to a large retrospective study from Memorial Sloan Kettering recently published in the JCO.
Annually, GSK awards fellowships to two second-year students and six first-year students based on academic achievement in different elements of the curriculum.
Research led by investigators at Memorial Sloan Kettering Cancer Center has shown that therapeutic cloning, also known as somatic-cell nuclear transfer (SCNT), can be used to treat Parkinson's disease in mice.
Dr. Offodile will serve as MSK’s “futurist,” leading strategy efforts and care transformation initiatives at MSK by continuing to develop the core infrastructure, management systems, and processes for enterprise strategy and business development.
Pexidartinib is the first drug approved specifically to treat tenosynovial giant cell tumor.